FDA/CDC

List of COVID-19 high-risk comorbidities expanded


 

The list of medical comorbidities associated with high risk for severe COVID-19 now includes moderate to severe asthma, diabetes, and substance use disorders, according to the Centers for Disease Control and Prevention.

Comorbidities associated with high risk for severe COVID-19

The CDC’s latest list consists of 17 conditions or groups of related conditions that may increase patients’ risk of developing severe outcomes of COVID-19, the CDC said on a web page intended for the general public.

On a separate page, the CDC defines severe outcomes “as hospitalization, admission to the intensive care unit, intubation or mechanical ventilation, or death.”

Asthma is included in the newly expanded list with other chronic lung diseases such as chronic obstructive pulmonary disease and cystic fibrosis; the list’s heart disease entry covers coronary artery disease, heart failure, cardiomyopathies, and hypertension, the CDC said.

Recommended Reading

COVID vaccines could lose their punch within a year, experts say
Federal Practitioner
CDC adds new medical conditions to COVID-19 high-risk list
Federal Practitioner
COVID-19 in 2020: Deaths and disparities
Federal Practitioner
AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?
Federal Practitioner
Children likely the ‘leading edge’ in spread of COVID-19 variants
Federal Practitioner
Excess deaths jump 23% in U.S. in 2020, mostly because of COVID-19
Federal Practitioner
Study suggests no added risk of blood clots in COVID-19 outpatients
Federal Practitioner
Researchers stress importance of second COVID-19 vaccine dose for infliximab users
Federal Practitioner
The pandemic is making periods unbearable for some women
Federal Practitioner
Risk for erectile dysfunction sixfold higher in men with COVID-19
Federal Practitioner